Status:

COMPLETED

The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases

Lead Sponsor:

Zhongshan Hospital Xiamen University

Conditions:

Inflammatory Bowel Disease(IBD)

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

There are many limitations in the current treatments of Inflammatory Bowel Diseases(IBD) which includes Ulcerative Colitis(UC) and Crohn's Disease(CD). Some patients have no or little reaction to the ...

Detailed Description

In this projects the investigators aim to re-establish a gut balance of intestinal microbiota through Standardized Intestinal Microbiota Transplantation for Ulcerative Colitis(UC) and Crohn's Disease(...

Eligibility Criteria

Inclusion

  • Standard or conventional medicine treatment ineffective of Inflammatory Bowel Diseases(IBD) patients
  • IBD patients with recurrent symptoms
  • IBD patients who had drug dependence or recurrence when reduced or discontinued use
  • Untreated IBD patients who voluntarily received Standardized Intestinal Microbiota Transplantation(IMT)
  • Written informed consent/assent as appropriate

Exclusion

  • IBD patients with contraindications for gastrointestinal endoscopy
  • IBD patients with indication of surgery
  • Moderate and severe renal injuty(serum creatinine\>2mg/dL or 177mmol/L), moderate and severe chronic obstructive pulmonary disease, severe hypertension, cerebrovascular accident, congestive heart failure, unstable angina pectoris
  • Other serious diseases that may interfere the recruitment or affect the survival, such as cancer or acquired immune deficiency syndrome
  • Mentally or legally disabled person
  • Preparing for pregnancy
  • Medical or social condition which in the opinion of the principal investigator would interfere with or prevent regular follow up
  • Participating in other clinical trials.

Key Trial Info

Start Date :

November 21 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2022

Estimated Enrollment :

35 Patients enrolled

Trial Details

Trial ID

NCT03426683

Start Date

November 21 2017

End Date

December 30 2022

Last Update

November 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Zhongshan Hospital Affiliated to Xiamen University

Xiamen, Fujian, China, 361000